Summary
Updated Aug 31, 2026
Naimish Patel is Chief Medical Officer of CRISPR Therapeutics AG (CRSP). 7 SEC Form 4 filings on record going back to 2024, most recently on 2 June 2026. Most recent open-market trade: sold $211K of CRSP on 1 June 2026. Lifetime open-market purchases: $50K. Lifetime open-market sales: $363K.
Recent Transactions
5Every recent SEC Form 4 transaction Naimish Patel has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Naimish Patel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Samarth Kulkarni - $10.76M of CRSP open-market activity in the last 12 months
- Raju Prasad - $5.10M of CRSP open-market activity in the last 12 months
- James R. Kasinger - $646K of CRSP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Naimish Patel?
Naimish Patel is a corporate insider, tracked as Chief Medical Officer of CRISPR Therapeutics AG (CRSP). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Naimish Patel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Naimish Patel been buying or selling stock?
Recorded transactions: 1 open-market purchase ($50K) and 2 open-market sales ($363K) across all tracked filings.
Where can I see all of Naimish Patel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Naimish Patel and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
